Skip to main content
Caplight Logo









Salspera, Inc.

Salspera, Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://salspera.com/

Last Round

IPO

Feb 2, 2026

Total Funding Raised

$680,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Salspera, Inc. is a biotechnology company that develops live biopharmaceutical immunotherapies for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

live biopharmaceuticalLBPimmunotherapysolid tumor treatmentcancer immunotherapySalmonella Typhimuriumgenetically modified bacteriatumor microenvironmentinterleukin-2IL-2oncolytic bacteriapancreatic cancerosteosarcomabiotechclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Salspera, Inc. Comparables

Compare Salspera, Inc. with similar companies based on industry and business-model similarity.

Salspera, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Actym Therapeutics
88%
Prokarium
83%
Sentinel BioTherapeutics
77%

Salspera, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOFeb 2, 2026

Key People

Founding team and executive leadership

Eddie Moradian

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    $85M raised in IPO round.

Salspera, Inc. Filings

Explore SEC and related filing metadata, where available.

Salspera, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Salspera, Inc.'s valuation, stock price, and market status.

Is Salspera, Inc. a public or private company?

Salspera, Inc. is a private company.

What is the current stock price of Salspera, Inc.?

Salspera, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Salspera, Inc. worth (valuation)?

Valuation information for Salspera, Inc. is not publicly available.

Can I buy Salspera, Inc. stock?

Salspera, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Salspera, Inc.'s last funding round?

Salspera, Inc.'s most recent funding round was IPO on February 2, 2026.

Who are the main investors in Salspera, Inc.?

Investor information for Salspera, Inc. is not publicly disclosed.

Will Salspera, Inc. IPO soon?

No public IPO plans have been announced for Salspera, Inc..

How can I track Salspera, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Salspera, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range2
Year Founded2017
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?